Narrative review / 2015
Gut microbiota trimethylamine (TMA) production potential was associated with symptomatic atherosclerosis in public metagenomic data sets.
The authors reviewed literature on gut microbiota-derived trimethylamine (TMA), a metabolite linked to atherosclerosis development, to demonstrate big data integration workflows. By translating elucidated microbial pathways for TMA production into genomic orthologs, public (meta-)genomic databases were mined and linked to metadata. Reviewing pathway abundance showed that TMA production potential is associated with symptomatic atherosclerosis and facilitated identification of previously uncharacterized TMA-producing bacteria.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review and metagenomic database analysis
- Who was studied
- Public metagenomic datasets and corresponding metadata
- What was measured
- Trimethylamine (TMA) production pathways and association with atherosclerosis
THE PAPER
Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine.
Falony G, Vieira-Silva S, Raes J. Annu Rev Microbiol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.